Stock listing
Burzynski Research Institute, Inc.
Selected listing: BZYR · OTC · USD · US
Burzynski Research Institute, Inc. (OTC:BZYR), Health Technology. Latest release May 12, 2026: Burzynski Research Institute warns it may miss Form 10-K filing…
- Ticker
- OTC:BZYR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- OTC
- Currency
- USD
About Burzynski Research Institute, Inc.
The company is involved in research and development in the field of cancer treatment. Its focus is on innovative therapies aimed at improving patient outcomes.
Latest news from Burzynski Research Institute, Inc.
Burzynski Research Institute warns it may miss Form 10-K filing as funding for SEC reporting ends
May 12, 2026
Stanislaw R. Burzynski named CFO and Secretary as Patryk P. Goscianski resigns at Burzynski Research Institute
April 23, 2026
BURZYNSKI RESEARCH INSTITUTE INC SEC 10-Q Report
January 13, 2026
Burzynski Research Institute Inc. Releases Q1 2024 10-Q Report
July 14, 2024
Burzynski Research Institute Inc. Releases Q3 2023 10-Q Report
January 15, 2024
Research Burzynski Research Institute, Inc.
Burzynski Research Institute, Inc. company profile
View the public company page for Burzynski Research Institute, Inc. on 6ix.
Burzynski Research Institute, Inc. news
Read company news and market updates connected to Burzynski Research Institute, Inc..
Burzynski Research Institute, Inc. investor events
Find investor webinars, events, and replay context for Burzynski Research Institute, Inc..